Xtant Medical Holdings Statistics
Total Valuation
XTNT has a market cap or net worth of $103.88 million. The enterprise value is $134.03 million.
Important Dates
The next confirmed earnings date is Tuesday, November 11, 2025, before market open.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XTNT has 140.00 million shares outstanding. The number of shares has increased by 6.41% in one year.
| Current Share Class | 140.00M |
| Shares Outstanding | 140.00M |
| Shares Change (YoY) | +6.41% |
| Shares Change (QoQ) | +3.66% |
| Owned by Insiders (%) | 18.81% |
| Owned by Institutions (%) | 8.26% |
| Float | 45.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.80 |
| Forward PS | 0.85 |
| PB Ratio | 2.13 |
| P/TBV Ratio | 3.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 69.21 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.05 |
| EV / EBITDA | 29.83 |
| EV / EBIT | 4,621.77 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.47, with a Debt / Equity ratio of 0.76.
| Current Ratio | 2.47 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | 6.75 |
| Debt / FCF | n/a |
| Interest Coverage | 0.01 |
Financial Efficiency
Return on equity (ROE) is -9.80% and return on invested capital (ROIC) is 0.02%.
| Return on Equity (ROE) | -9.80% |
| Return on Assets (ROA) | 0.02% |
| Return on Invested Capital (ROIC) | 0.02% |
| Return on Capital Employed (ROCE) | 0.04% |
| Revenue Per Employee | $550,716 |
| Profits Per Employee | -$19,741 |
| Employee Count | 232 |
| Asset Turnover | 1.28 |
| Inventory Turnover | 1.26 |
Taxes
In the past 12 months, XTNT has paid $313,000 in taxes.
| Income Tax | 313,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.93% in the last 52 weeks. The beta is -0.09, so XTNT's price volatility has been lower than the market average.
| Beta (5Y) | -0.09 |
| 52-Week Price Change | +38.93% |
| 50-Day Moving Average | 0.70 |
| 200-Day Moving Average | 0.60 |
| Relative Strength Index (RSI) | 46.56 |
| Average Volume (20 Days) | 409,144 |
Short Selling Information
The latest short interest is 104,252, so 0.07% of the outstanding shares have been sold short.
| Short Interest | 104,252 |
| Short Previous Month | 62,199 |
| Short % of Shares Out | 0.07% |
| Short % of Float | 0.23% |
| Short Ratio (days to cover) | 0.53 |
Income Statement
In the last 12 months, XTNT had revenue of $127.77 million and -$4.58 million in losses. Loss per share was -$0.04.
| Revenue | 127.77M |
| Gross Profit | 76.86M |
| Operating Income | 29,000 |
| Pretax Income | -4.27M |
| Net Income | -4.58M |
| EBITDA | 4.49M |
| EBIT | 29,000 |
| Loss Per Share | -$0.04 |
Full Income StatementBalance Sheet
The company has $6.92 million in cash and $37.07 million in debt, giving a net cash position of -$30.15 million or -$0.22 per share.
| Cash & Cash Equivalents | 6.92M |
| Total Debt | 37.07M |
| Net Cash | -30.15M |
| Net Cash Per Share | -$0.22 |
| Equity (Book Value) | 48.50M |
| Book Value Per Share | 0.35 |
| Working Capital | 44.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.50 million and capital expenditures -$4.33 million, giving a free cash flow of -$2.83 million.
| Operating Cash Flow | 1.50M |
| Capital Expenditures | -4.33M |
| Free Cash Flow | -2.83M |
| FCF Per Share | -$0.02 |
Full Cash Flow StatementMargins
Gross margin is 60.16%, with operating and profit margins of 0.02% and -3.58%.
| Gross Margin | 60.16% |
| Operating Margin | 0.02% |
| Pretax Margin | -3.34% |
| Profit Margin | -3.58% |
| EBITDA Margin | 3.52% |
| EBIT Margin | 0.02% |
| FCF Margin | n/a |
Dividends & Yields
XTNT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.41% |
| Shareholder Yield | -6.41% |
| Earnings Yield | -4.41% |
| FCF Yield | -2.73% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 14, 2018. It was a reverse split with a ratio of 1:12.
| Last Split Date | Feb 14, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
XTNT has an Altman Z-Score of -0.86 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.86 |
| Piotroski F-Score | 4 |
